Medical Product Outsourcing

Cardiovascular

Abbott Recalls Ellipse ICDs

The ICDs were recalled due to exposed aluminum wires that may prevent defibrillation therapy.

U.S. Food and Drug Administration 08.05.19

Abbott Launches Rapid Point-of-Care HbA1c Test to Aid in the Diagnosis of Diabetes

The Afinion HbA1c Dx test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation.

PRNewswire 06.17.19

Cardiovascular | Patient Monitoring

Abbott Launches Next Gen of the World’s First Smartphone-Compatible Implantable Heart Monitor

The ConfirmRx ICM offers a smarter approach to 24/7 heart monitoring for people with irregular heartbeats.

Abbott Laboratories 05.06.19

Digital Health | Patient Monitoring | Software & IT

Novo Nordisk Digital Insulin Pen Now Compatible with Abbott's FreeStyle Libre CGM

Insulin data can be shared between Novo Nordisk connected insulin pens and digital health tools compatible with FreeStyle Libre products.

Abbott Laboratories 02.20.19

Abbott Promotes Exec VP of Medical Devices to President & COO

22-year veteran Robert B Ford to expand his current role, taking on responsibility for all of Abbott's operating businesses.

Abbott Laboratories 10.16.18

$16.2 Billion ($27.4B total) KEY EXECUTIVES: Miles D. White, Chairman and CEO Brian B. Yoor, Exec. VP, Finance and CFO Brian J. Blaser, Exec. VP, Diagnostics Products Robert B. Ford, Exec. VP, Medical Devices Sharon Bracken, Sr. VP, Rapid Dia…

07.26.18

Diagnostics

FDA OKs Abbott's Point-of-Care Diabetes Diagnostic Test

First-ever point-of-care HbA1c assay cleared for diagnosing diabetes and identifying patients at risk for diabetes.

Abbott Laboratories 06.22.18

Cardiovascular | Surgical

FDA Approves Abbott's Xience Sierra Everolimus-Eluting Coronary Stent

New features help doctors treat more difficult-to-reach blockages in patients' arteries.

PR Newswire 05.23.18

10. Abbott Laboratories

$10.1 Billion ($20.9B total) KEY EXECUTIVES: Miles D. White, Chairman and CEO Brian J. Blaser, Exec. VP, Diagnostics Products Robert B. Ford, Exec. VP, Medical Devices Michael T. Rousseau, President, Cardiovascular and Neuromodulation Br…

07.26.17

Software & IT | Testing

The Curious Case of Abbott and Alere

As MPO readers are certainly aware, Abbott Laboratories has been quite active in the M&A department this year. Following the string of medtech industry consolidation efforts—which shows absolutely no signs of slowing—Abbott purchased…

Sam Brusco, Associate Editor 10.12.16